Argus Research Downgrades Integra Lifesciences to Hold

Benzinga Newsdesk www.benzinga.com Negative 87.6%

Neg 87.6% Neu 0% Pos 0%

Argus Research analyst David Toung downgrades Integra Lifesciences (NASDAQ:IART) from Buy to Hold.

Comments

No comments yet. Be the first!